(NASDAQ: SRRK) Scholar Rock Holding's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.85%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.4%.
Scholar Rock Holding's revenue in 2025 is $0.On average, 7 Wall Street analysts forecast SRRK's revenue for 2025 to be $668,416,756, with the lowest SRRK revenue forecast at $153,811,810, and the highest SRRK revenue forecast at $1,898,911,240. On average, 7 Wall Street analysts forecast SRRK's revenue for 2026 to be $14,601,108,307, with the lowest SRRK revenue forecast at $9,494,556,200, and the highest SRRK revenue forecast at $21,172,860,326.
In 2027, SRRK is forecast to generate $33,666,556,938 in revenue, with the lowest revenue forecast at $22,008,381,272 and the highest revenue forecast at $42,915,394,024.